Is Spravato Safe? Addressing the 6 Most Common Patient Concerns
Is Spravato safe is the question I hear from almost every new patient — and it's a fair one. The medication is FDA-approved and the safety protocol is rigorous, but it shares a parent compound with a substance most people associate with anesthesia and recreational use. Here are the six concerns patients raise most often, answered without spin.
Is Spravato addictive?
This is the most common concern. The honest answer: at the doses and intervals used clinically, with the REMS observation protocol, Spravato's addiction risk in clinical trials and post-market use has been low. The clinic-only administration is part of why. You don't have access to it at home. You don't decide when you take it. This structure is intentional — it prevents the patterns that lead to misuse.
How is it different from recreational ketamine?
Recreational ketamine use involves unknown doses, unknown purity, no medical supervision, and often combinations with other substances. Spravato is a precisely dosed nasal spray administered in a clinic under continuous monitoring. The molecule is related; the experience is meaningfully different because the context is meaningfully different.
Will I lose control during a session?
No. You're awake, you can speak, you can move, you can ask for the bathroom. The experience is closer to a vivid daydream than to anesthesia. Some patients feel pleasantly disconnected from their usual emotional weight for an hour; that's the desired effect, not a loss of control.
Are there long-term cognitive or organ effects?
At clinical doses and frequencies, current evidence does not show long-term cognitive impairment or organ damage. Chronic high-dose recreational ketamine use can cause bladder problems and other issues, but the dosing in Spravato is far below those levels and is bounded by your treatment plan.
Driving, working, and parenting on treatment days
You cannot drive for 24 hours after a session. Most patients take the rest of the dosing day off. By the next morning, most are fully functional — including for work and parenting. We help you plan dosing days around your real life.
What the REMS program actually does for you
REMS (Risk Evaluation and Mitigation Strategy) is the FDA's safety system for Spravato. It requires every provider and clinic to be certified, every patient to be enrolled, every session to involve observation, and every dose to be tracked. It exists to make sure Spravato is delivered safely. You'll sign a brief enrollment form before your first session; that's the patient-facing piece.
CTA
Bring your concerns to a free consult — we'd rather answer ten questions in advance than have any lingering on your treatment day.